Eevia Health Plc receives a 1 MSEK/96 KEUR sales order for a Bilberry extract product

Report this content

Eevia Health Plc, (”Eevia” or ”The Company”), has received a 96 KEUR sales order from a European nutraceutical brand owner.

The customer is a European brand owner headquartered in Sweden. The customer is marketing its consumer products in over 50.000 pharmacies, health food shops, and other retail outlets across 36 countries, including China and USA.

The sales value to Eevia of this new order is c. 96 000 EUR. The product is a Bilberry extract standardized for anthocyanins and is a repeat order. This is one of the customers Eevia services without using a distributor. The business has been developed over the last few years, with growing repeat orders. Eevia is selected due to the high quality and authenticity of the product.


“Although it is a small order, we are very pleased to do repeat business with this customer. After a few years of being backlogged in production from overseas contracts, Eevia is now very focused on strengthening the sales support of customers in Europe. The European customer base has potential.  Customers like this are adding quality to our customer portfolio. They are a central element of the sales plans for 2023 and 2024.” says Stein Ulve, CEO of Eevia Health.



For further information, please contact:

Stein Ulve, CEO, Eevia Health Plc                          


Telephone: +358 400 22 5967                         





Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.

Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia’s other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion.

Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name EEVIA.

To learn more, please visit or follow Eevia Health on LinkedIn @EeviaHealth.